02/20/2025
4:00 PM | AbbVie (Filer)
| Form 424B5 | |
02/19/2025
8:22 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/18/2025
8:25 PM | AbbVie (Subject)
| Form FWP | |
02/18/2025
7:41 AM | AbbVie (Filer)
| Form 424B5 | |
02/14/2025
12:17 PM | AbbVie (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
6:30 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2025
6:42 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
7:31 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
4:00 PM | AbbVie (Issuer)
Buckbee Kevin K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
4:34 PM | AbbVie (Subject)
Buckbee Kevin K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/04/2024
3:15 PM | AbbVie (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Get the Latest News and Ratings for ABBV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for AbbVie and its competitors with MarketBeat's FREE daily newsletter. |
11/04/2024
3:16 PM | AbbVie (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/04/2024
1:19 PM | AbbVie (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2024
6:43 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:07 PM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
4:00 PM | AbbVie (Issuer)
Quaggin Susan E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:00 PM | AbbVie (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:00 PM | AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:00 PM | AbbVie (Issuer)
RAPP EDWARD J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:06 PM | AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
2:30 PM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
4:40 PM | AbbVie (Subject)
Hudson Thomas J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
3:22 PM | AbbVie (Subject)
Hudson Thomas J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
2:00 PM | AbbVie (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2024
9:54 AM | AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024
6:41 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
3:40 PM | AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
3:17 PM | AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024
1:07 PM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
4:00 PM | AbbVie (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/03/2024
10:28 AM | AbbVie (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
| Form 25-NSE | |
05/17/2024
8:03 AM | AbbVie (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
| Form 25-NSE | |
05/07/2024
7:16 PM | AbbVie (Issuer)
Davis Jennifer L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
5:30 PM | AbbVie (Issuer)
WADDELL FREDERICK H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
5:30 PM | AbbVie (Issuer)
TILTON GLENN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
5:30 PM | AbbVie (Issuer)
BURNSIDE WILLIAM H.L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
5:30 PM | AbbVie (Issuer)
Roberts Rebecca B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
5:30 PM | AbbVie (Issuer)
MEYER MELODY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
5:30 PM | AbbVie (Issuer)
Hart Brett J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
5:30 PM | AbbVie (Issuer)
AUSTIN ROXANNE S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
5:30 PM | AbbVie (Issuer)
FREYMAN THOMAS C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad) If you missed out on the big boom in Nvidia…
Listen up, because according to Nvidia's own CEO…
Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry. You MUST act before March 17th. |
05/07/2024
5:30 PM | AbbVie (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
5:30 PM | AbbVie (Issuer)
RAPP EDWARD J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
5:31 PM | AbbVie (Issuer)
Quaggin Susan E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
10:04 AM | AbbVie (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
6:43 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
4:00 PM | AbbVie (Issuer)
RAPP EDWARD J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
4:00 PM | AbbVie (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
4:00 PM | AbbVie (Issuer)
Quaggin Susan E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
1:31 PM | AbbVie (Subject)
Chevedden John (Filed by)
| Form PX14A6G | |
03/22/2024
4:00 PM | AbbVie (Issuer)
Donoghoe Nicholas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
1:29 PM | AbbVie (Subject)
Donoghoe Nicholas (Reporting)
| Form 144/A | |
03/20/2024
6:30 PM | AbbVie (Subject)
Donoghoe Nicholas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
4:00 PM | AbbVie (Issuer)
Stewart Jeffrey Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
3:27 PM | AbbVie (Filer)
| Form ARS | |
03/05/2024
4:30 PM | AbbVie (Issuer)
RICHMOND TIMOTHY J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
6:53 PM | AbbVie (Subject)
Reents Scott T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:50 PM | AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Donoghoe Nicholas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Thakkar Roopal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Hudson Thomas J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
RICHMOND TIMOTHY J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Stewart Jeffrey Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Siatis Perry C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Michael Robert A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Buckbee Kevin K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:50 PM | AbbVie (Issuer)
Reents Scott T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
3:20 PM | AbbVie (Subject)
RICHMOND TIMOTHY J. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
5:06 PM | AbbVie (Subject)
Buckbee Kevin K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
4:33 PM | AbbVie (Subject)
Michael Robert A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
4:00 PM | AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
4:52 PM | AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
5:12 AM | AbbVie (Filer)
| Form 424B5 | |
02/23/2024
4:00 PM | AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
8:14 PM | AbbVie (Subject)
| Form FWP | |
02/21/2024
5:00 PM | AbbVie (Subject)
SALEKI-GERHARDT AZITA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
7:39 AM | AbbVie (Filer)
| Form 424B5 | |
